Study Notes on Vector Borne Diseases - Part 1: Lyme Disease

Introduction to Vector-Borne Diseases

  • Overview of vector-borne diseases.

  • Definition of vector-borne diseases: Diseases transmitted through vectors such as insects (e.g., mosquitoes, ticks, lice, fleas, and mites).

  • Diseases covered in this section:

    • Lyme disease

    • Ehrlichiosis

    • Rocky Mountain spotted fever

    • Babesiosis

    • Chikungunya

    • Dengue fever

    • West Nile fever

    • Zika virus

Lyme Disease

Causative Agent

  • Lyme disease is caused by the spirochete bacteria Borrelia burgdorferi.

  • Characteristics of spirochetes:

    • Corkscrew-shaped bacteria.

    • Visible using darkfield microscopy but cannot be cultured.

Transmission

  • Transmission vector: Hard-bodied ticks, specifically from the Ixodes species.

  • Hosts for the ticks include:

    • White-footed mouse

    • White-tailed deer

  • Tick bites facilitate transmission of B. burgdorferi to humans.

  • Two critical factors for transmission:

    • The tick must carry B. burgdorferi.

    • The tick must transmit the spirochete after biting the human.

Life Cycle of Ticks

  • Development stages of ticks:

    1. Female lays eggs in year one.

    2. Six-legged larvae hatch from eggs, feed on mice, and become infected.

    • Remain dormant during fall/winter.

    1. In spring of year two, larvae develop into nymphs (eight-legged).

    • Still infected, capable of feeding on humans.

    1. Nymphs can transmit the infection to humans.

    2. Ticks can also feed on dogs and cats, which may develop into adult ticks on deer for mating.

Global Distribution

  • Lyme disease prevalence:

    • Commonly found in the Northeastern and Midwestern U.S. states.

    • Endemic in more than 15 U.S. states and also present in Europe and Asia.

  • Distribution map:

    • Dense concentration of Lyme disease cases in Northeastern U.S. (e.g., Maine) and parts of the Midwest (e.g., Minnesota, Wisconsin).

Clinical Features of Lyme Disease

Stages of Lyme Disease

  1. Stage One (4 weeks post-infection):

    • Symptoms:

      • Erythema migrans: Target lesion appearance.

      • Flu-like symptoms (may complicate diagnosis).

  2. Stage Two:

    • Latent period with minimal symptoms.

    • Potential organ involvement without noticeable disease.

    • May experience arthritis and neurological complications over weeks or years.

  3. Stage Three:

    • Occurs weeks to years after initial infection.

    • Common symptoms:

      • Arthritis

      • Neurological issues, including meningitis.

    • Transplacental transmission confirmed in rare cases.

      • High mortality risk for infants born with Lyme.

Detection of Lyme Disease

  • Detection methods include:

    • Blood smear for visualizing spirochetes.

    • Skin biopsy, particularly during target rash presentation.

  • Challenges in diagnosis due to varying stages of disease progression.

  • Importance of patient history and serological testing:

    • Current methods include ELISA for antibodies and molecular testing.

Serological Testing

  • IgM antibodies: Generally appear within several months post-infection.

  • IgG antibodies: Typically appear around thirty days after infection, persisting for years.

  • Testing considerations:

    • Indicators of active infection versus resolved disease.

Diagnostic Protocol

  • Initial diagnostic test: EIA or IFA (for antibody detection).

    • If negative, consider alternate diagnoses or conduct follow-up testing.

  • If positive:

    • For early cases (less than 30 days), perform Western blot (IgG and IgM).

    • For later cases (more than 30 days), check only IgG.

Western Blot Methodology

  • Overview of the Western blot procedure:

    • Similarity to electrophoresis but vertical.

    • Gel separation followed by membrane transfer.

    • Addition of primary and secondary antibodies to visualize results.

  • Role of the Western blot:

    • Confirmatory test for reactive EIA/IFA.

False Positives

  • Potential for false positives in Lyme disease tests (2-5% of healthy individuals).

    • Common causes include:

    • Cross-reactivity with syphilis (also a spirochete).

    • Inflammatory disorders (e.g., rheumatoid arthritis).

Treatment and Prevention

Treatment

  • Antibiotic protocols exist for treating Lyme disease.

  • Effectiveness is dependent on timely diagnosis—long-term outcomes uncertain if not caught early.

Prevention Strategies

  • Important prevention tactics include:

    • Checking for ticks after outdoor activities (especially in wooded areas).

    • Regularly inspecting pets for ticks.

    • Wearing light-colored clothing to spot ticks easily.

    • Using preventive measures (e.g., pest repellents).

    • Tucking pants into socks to minimize skin exposure to ticks.

Conclusion

  • Summary of Lyme disease characteristics, transmission, clinical presentation, diagnosis, and preventive measures.

  • The presentation concludes the discussion of vector-borne diseases, focusing on Lyme disease as a significant example of such diseases.